Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to Support Gene Therapy and Protein Drug Development 2020-05-19 18:55
Invivoscribe Announces FDA Approval for Distribution of the LeukoStrat CDx FLT3 Mutation Assay as an IVD Kit in the United States 2020-05-19 18:00
Excelra to Provide Lawrence Livermore National Laboratory With Small Molecule Medicinal Chemistry Intelligence Data to Help Develop Drug Design Platform 2020-05-19 10:00
Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic 2020-05-19 08:15
WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States 2020-05-19 08:00
Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen 2020-05-15 11:52
AGC Biologics to Participate in First-Ever BIO Digital Conference 2020-05-14 20:30
Halodine(R) Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19) 2020-05-14 09:26
Dreamwood(TM) Offers Olfactive Warmth, Cosmetic Benefits and Positive Impact 2020-05-13 21:53
CMAB Biopharma's development and manufacturing platform successfully completes Q-1802 bispecific antibody project for QureBio within 9 months 2020-05-13 18:29
Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment 2020-05-13 17:51
Hummingbird Bioscience Closes US$25 Million Investment With Series B Extension 2020-05-11 08:00
Sai Life Sciences Joins the Global 'COVID Moonshot' Project 2020-05-07 09:00
Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer 2020-05-07 07:30
Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials 2020-05-05 20:05
Tessa Therapeutics Announces New Executive Leadership 2020-05-05 00:00
Ascentage Pharma's Core Drug Candidate HQP1351 Granted Orphan Drug Designation by the US FDA for the Treatment of Patients with Chronic Myeloid Leukemia 2020-05-04 18:30
Only science can give an exact answer to the origin of novel coronavirus 2020-04-28 23:22
INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June 2020-04-28 20:00
PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19 2020-04-28 18:57
1 167 168 169 170 171 229